12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Modufolin: Phase I/II started

Isofol began the single-blind, Swedish Phase I/II ISO-CC-002 trial to compare 60 and 200 mg/m 2 IV bolus of Modufolin vs. 60 and 200 mg/m 2 IV bolus...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >